Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2632 (LINC02632)
- Target
- LINC02632
- Molecular classification
- Other (Long intergenic non-coding RNA, lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2632 (LINC02632) encodes a long intergenic non-coding RNA—a type of RNA molecule longer than 200 nucleotides that is transcribed autonomously and does not overlap with any protein-coding genes. LincRNAs, including LINC02632, function primarily in regulating gene expression, remodeling chromatin, organizing genome architecture, and may exhibit tissue-specific regulatory roles. Unlike classical drug targets, LINC02632 does not encode a protein and is not known to act as a receptor, enzyme, transporter, or transcription factor. Its precise physiological or pathological roles have not been extensively characterized to date
- Other names
- LINC02632long intergenic non-protein coding RNA 2632
02
Mechanism of action
Not applicable. As there are no known drugs targeting LINC02632, there is no defined mechanism of action
03
Biological functions
Chromatin remodelingRegulation of genome architectureRNA stabilizationTranscription regulationFine-tuning expression of neighboring genes
04
Disease associations
Other. Although lincRNAs have emerging roles in various diseases, including cancer and cell fate decisions, there is no direct evidence for LINC02632’s involvement in specific diseases as of current knowledge
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2632 (LINC02632).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2632 (LINC02632).